Mario Isaza-Ruget

Mario Isaza-Ruget

Auto-generated profile, based on publicly available information

Mario Isaza-Ruget


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2024 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
MIMario A. Isaza-Ruget
Mario A. Isaza-Ruget
NYNancy Yomayusa
Nancy Yomayusa
CGCamilo A. González
Camilo A. González
CHCatherine Alvarado H.
Catherine Alvarado H.
FVFabio A. de Oro V.
Fabio A. de Oro V.
MCMaría I. Conde
María I. Conde
Background: The use of tools that allow estimation of the probability of progression of chronic kidney disease (CKD) to advanced stages has not yet achieved significant practical importance in clinical setting. This study aimed to develop and validate a machine learning-based model for predicting the need for renal replacement therapy (RRT) and disease progression for patients with stage 3–5 CKD. Methods: This was a retrospective, closed cohort, observational study. Patients with CKD affiliated with a private insurer with five-year follow-up data were selected. Demographic, clinical, and laboratory variables were included, and the models were developed based on machine learning methods. The outcomes were CKD progression, a significant decrease in the estimated glomerular filtration rate (eGFR), and the need for RRT. Results: Three prediction models were developed—Model 1 (risk at 4.5 years, n = 1446) with a F1 of 0.82, 0.53, and 0.55 for RRT, stage progression, and reduction in the eGFR, respectively,— Model 2 (time- to-event, n = 2143) with a C-index of 0.89, 0.67, and 0.67 for RRT, stage progression, reduction in the eGFR, respectively, and Model 3 (reduced Model 2) with C-index = 0.68, 0.68 and 0.88, for RRT, stage progression, reduction in the eGFR, respectively. Conclusion: The time-to-event model performed well in predicting the three outcomes of CKD progression at five years. This model can be useful for predicting the onset and time of occurrence of the outcomes of interest in the population with established CKD.

15 May 2019 in Revista de Saúde Pública
Verified
Journal Article
Open access
PDF file
AGAbel E González-Vélez
Abel E González-Vélez
CMClaudia Carolina Colmenares Mejía
Claudia Carolina Colmenares Mejía
EPEduardo Low Padilla
Eduardo Low Padilla
SMSandra Yadira Moreno Marín
Sandra Yadira Moreno Marín
PBPaola Andrea Rengifo Bobadilla
Paola Andrea Rengifo Bobadilla
MRMario Arturo Isaza Ruget
Mario Arturo Isaza Ruget
OBJECTIVE: To analyze the emergency hospitalizations trend for ambulatory care sensitive conditions between 2011 and 2015 in a health insureance company of the Colombian Social Security General System. METHODS: A log-linear analysis based on age-adjusted hospitalization rates for ambulatory care sensitive conditions in the Entidad Promotora de Salud Sanitas was used to estimate the annual percentage change in these rates and to identify joinponts of the rates. Data was collected from administrative sources. RESULTS: There were 38,530 hospitalizations for ambulatory care sensitive conditions in 26,501 Entidad Promotora de Salud Sanitas enrollees, with a significant decrease in hospitalization rates. The annual percentage change estimated for the period was -9.5% with no significant joinpoints throughout the time interval. CONCLUSIONS: A significant reduction in hospital admissions due to ambulatory care sensitive conditions in Entidad Promotora de Salud Sanitas enrollees were reported for the last five years in this study.

26 October 2023 in International Journal of Diabetes in Developing Countries
Verified
Journal Article
Closed access
PDF file
CCClaudia C. Colmenares-Mejía
Claudia C. Colmenares-Mejía
JAJuan Carlos Rincón Acuña
Juan Carlos Rincón Acuña
ACAndrés Cely
Andrés Cely
AGAbel E. González-Vélez
Abel E. González-Vélez
ACAndrea Castillo
Andrea Castillo
MIMario A. Isaza-Ruget
Mario A. Isaza-Ruget

1 June 2007 in Revista de Salud Pública
Verified
Journal Article
Closed access
PDF file
OMOscar Martínez-Nieto
Oscar Martínez-Nieto
MIMario Isaza-Ruget
Mario Isaza-Ruget
NRNancy Rangel-Espinosa
Nancy Rangel-Espinosa
OMOlga L. Morales-Reyes
Olga L. Morales-Reyes
Objetivo Determinar la prevalencia de anticuerpos para HTLV I/II, en los donantes de sangre del Banco de Sangre de la Clínica Reina Sofía, ubicada en Bogotá, Colombia. Métodos Fueron incluidas las muestras de todos los donantes de sangre en el período comprendido entre Abril de 1999 y Agosto de 2004. A estas muestras se les realizó un ELISA para identificación de los virus HTLV I/II; a los donantes con muestras reactivas se les tomó una nueva muestra, la cual se confirmó mediante Western blot (WB). Se analizaron las encuestas de todos los donantes con pruebas reactivas para HTLV I/II en el periodo descrito y se diligenció un formulario con las variables. Resultados La población total de donantes de sangre estudiados en los cinco años fue de 8 913 donantes, 5 883 (66 %) hombres y 3 030 (34 %) mujeres, con un promedio de 37 años; de los cuales 26 (0,3 %) tuvieron ELISA doblemente reactivo para HTLV I/II y, de estos, solo seis pacientes fueron confirmados mediante WB, los cuales representan una prevalencia de 0,07 % Conclusión Aunque nuestros hallazgos sugieren una baja seroprevalencia para HTLV I/II, nos permiten resaltar la importancia de implantar la prueba de detección de anticuerpos contra estos virus en todos los Bancos de Sangre del país junto con las demás pruebas que ya son indispensables según la legislación colombiana para poder suministrar sangre y hemocomponentes de calidad.

17 June 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
MAMauricio Arcos-Burgos
Mauricio Arcos-Burgos
MAMauricio Arcos-Holzinger
Mauricio Arcos-Holzinger
CMClaudio Mastronardi
Claudio Mastronardi
MIMario A. Isaza-Ruget
Mario A. Isaza-Ruget
Jorge I. VélezJorge I. Vélez
Jorge I. Vélez
Brett Andrew LidburyBrett Andrew Lidbury
Brett Andrew Lidbury
Background/Objectives: The aetiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), a chronic and severe debilitating disease with a complex phenotype, remains elusive. Associations with infectious diseases and autoimmune and neuropsychiatric disorders have been observed, without the identification of mechanisms. Previous studies suggest that genetic predisposition plays a role, but results are difficult to replicate, with Genome-Wide Association Studies of ME/CFS being challenging due to the relative rareness and heterogeneity of the disorder. Methods: We studied a well-defined Australian patient cohort diagnosed via the International Consensus Criteria, recruited by a specialist ME/CFS clinic. The whole-exome sequences of 77 patients were contrasted against genome variation in the 1000 Genome Project’s genome-matched population. Results: Significant associations with ME/CFS were harboured in genes that belong to the Neuroblastoma Breakpoint Family encoding Olduvai (DUF1220) domains, namely NBPF1 (rs3897177, p-value = 3.15 × 10−8), NBPF10 (rs1553120233, p-value = 9.262 × 10−13), and NBPF16 (rs200632836, p-value = 1.04 × 10−6). Other significantly associated variants were detected in the ATR, RSPH10B, ADGRE5-CD97, and NTRK2 genes, among others. Replication of these results was attempted via a GWAS on raw data from a US cohort, which confirmed shared significant associations with variation identified in the PTPRD, CSMD3, RAPGEF5, DCC, ALDH18A1, GALNT16, UNC79, and NCOA3 genes. Conclusions: These genes are involved in cortical neurogenesis, brain evolution, and neuroblastoma, and have been implicated by several studies in schizophrenia and autism. The sharing of these associations by the two cohorts supports their validity and grants the necessity of future studies to evaluate the implications for ME/CFS aetiology.

14 March 2026 in Medical Sciences
Verified
Journal Article
Open access
PDF file
JMJuan Esteban Morales-Mendoza
Juan Esteban Morales-Mendoza
MSMaría del Pilar Suarez-Ramos
María del Pilar Suarez-Ramos
MGMarcela Godoy-Corredor
Marcela Godoy-Corredor
NLNatalia Gomez Lopera
Natalia Gomez Lopera
JCJuan Felipe Combariza
Juan Felipe Combariza
MIMario A. Isaza-Ruget
Mario A. Isaza-Ruget
Background: Hemoglobin (Hb) and hematocrit (Hct) reference intervals (RIs) are critical for diagnosing hematological disorders. However, existing reference values often do not account for demographic and environmental variability. Particularly in countries with altitude gradients, such as Colombia, the absence of locally adjusted intervals may lead to the misclassification of anemia and polycythemia. Therefore, this study aims to establish sex-, age-, and altitude-specific reference intervals for Hb and Hct within the Colombian adult population via an indirect, big-data-based methodology. Methods: This retrospective cross-sectional study used 3.1 million Hb and Hct test results nationwide between 2022 and 2024. After applying the exclusion criteria, Hb data from 667,857 individuals and Hct data from 662,024 individuals were included. The population was stratified by sex, age, and altitude into <1100 m above sea level (m.a.s.l.), 1100–2000 m.a.s.l., and 2000–3000 m.a.s.l. Reference intervals (RIs) were estimated via the refineR algorithm, and the results were compared across altitude categories and against World Health Organization (WHO) anemia and polycythemia thresholds. Results: Hb and Hct concentrations increased with altitude in all sexes and age groups. Compared with women, men presented higher mean values and narrower RIs, whereas older adults presented greater variability. Compared with WHO thresholds, a significant proportion of individuals living above 2000 m exceeded polycythemia cutoffs without clinical evidence of disease, suggesting the need for altitude-adjusted diagnostic criteria. Conclusions: This study provides the first large-scale, data-driven reference intervals for Hb and Hct in Colombia, adjusted for altitude, sex, and age. The implementation of locally derived RIs may improve diagnostic accuracy and prevent the over- or underdiagnosis of hematological disorders, with direct implications for clinical decision-making and public health policy.